(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Syncona Ltd on Thursday said its net asset value increased during the first quarter of its financial year, citing strong clinical execution. Read More
(Alliance News) - The FTSE 100 was called in the green on Friday, while new UK labour market data has shown "modest growth" in new postings last month. Read More
(Alliance News) - London stocks were mostly lower at midday on Thursday, after the Bank of England left its key rates unchanged at 4.25%. However, three Monetary Policy Committee members voted for a 25 basis point cut. Read More
(Alliance News) - Syncona Ltd shares climbed on Thursday as it proposed a change of investment objective to move to an orderly realisation of assets, as it reported a decline in net asset value. Read More
(Alliance News) - Stock prices in London opened mostly in the red on Thursday, with US markets closed for Juneteenth and all eyes on the Bank of England's interest rate decision. Read More
(Alliance News) - The FTSE 100 was called to open lower on Thursday, ahead of the Bank of England's interest rate decision at midday London time. Read More
Syncona Ltd - London-based investor in healthcare companies - Portfolio company Spur Therapeutics Ltd announces new data from its gene therapy programmes in Gaucher disease, adrenomyeloneuropathy (AMN) and GBA1 Parkinson's disease, presented at the annual meeting of the American Society of Gene & Cell Therapy. Read More
(Alliance News) - Syncona Ltd on Wednesday noted its investee Beacon Therapeutics Holdings Ltd received positive data from its trial of laru-zova for the treatment of patients with X-linked retinitis pigmentosa. Read More
(Alliance News) - Syncona Ltd on Thursday reported a negative net asset value total return for the financial year to date, despite NAV rising during its third quarter. Read More
(Alliance News) - Syncona Ltd on Wednesday said portfolio company Achilles Therapeutics PLC is planning to return capital to shareholders though a members' solvent voluntary liquidation. Read More
(Alliance News) - Stock prices in London were mostly lower at midday on Friday as market participants continue digesting US jobless data and unrest in Mozambique puts miners on edge. Read More
(Alliance News) - Syncona Ltd on Friday said one of its investments Achilles Therapeutics PLC has sold its technology assets to AstraZeneca PLC for USD12 million. Read More
(Alliance News) - The FTSE 100 index in London was called slightly lower on Friday, as investors digest holiday-season sales results in the US and UK. Read More
(Alliance News) - Syncona Ltd on Friday reported promising trial results for the drug laru-zova, the lead asset of Syncona subsidiary Beacon Therapeutics Holdings Ltd. Read More
